Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Will biosimilars burst into a $36B U.S. market?

It is easy to create generics from conventional drugs, but not so for biologics, which involve active biological ingredients such as proteins that can be leveraged to treat cancer and a range of other diseases. Biosimilars, which mimic biologics as closely as possible, could be the next big thing in the U.S., but a hot debate has been pitched over what to name these drugs.

Thumbnail

Varian to repurchase another 6 million shares of stock

Varian Medical Systems, makers of radiation oncology technology announced Aug. 18 that the company’s board of directors authorized an additional repurchase of six million shares of common stock until December 31, 2015.

Thumbnail

Telik gets $1.5M for phase II pancreatic PET agent

A $1.5 million contract for the development of an investigative, monoclonal-antibody based PET radiotracer that can detect pancreatic cancer has been awarded to Telik, the Palo Alto-based pharmaceutical company announced today.

Thumbnail

MD Anderson and Memorial Hermann to partner for breast screening network

Starting in late November, the University of Texas MD Anderson Cancer Center will become the exclusive provider of professional breast radiology services for five breast care centers in the Memorial Hermann Health System, according to an announcement from the two organizations.

Optogenetics lights up neurons after stroke

A treatment for stroke involving optogenetics fires up neurons in the motor cortex by way of a beam of light. This treatment has been shown in preclinical research to improve movement and coordination after a stroke, say researchers at Stanford University in Stanford, Calif.

Thumbnail

Nanomedicine: Cancer immunotherapy amplifies patients’ immune cells outside the body

An investigational cancer immunotherapy leverages the power of nanotube-polymer composites to create an environment where immune cells can be incubated and made significantly stronger outside the body and then injected back into the blood to blast off a stronger offense against cancer, Yale University announced Aug. 13.

Thumbnail

Reassessing the standard: Radioiodine therapy for thyroid cancer

Radioiodine therapy has been around for a long time now as an effective treatment for thyroid cancer. However there may be some scenarios in which an alternative or combined treatment may be better suited, according to a review published Aug. 11 in the Journal of Nuclear Medicine.

Thumbnail

MRI detects recurring breast cancer missed by other modalities

Single-screening MRI can detect recurring breast cancer missed by ultrasound and mammography, suggests a study published in the August issue of Radiology.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.